CAP PT Survey Master Activity List - 2019
CAP PT Survey Master Activity List - 2019
Page 1 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
All Common All Common Common (CAP Office use) Y
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 5 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Anatomic Pathology Surgical Pathology ER and/or PgR, IHC path interp (off-site Y PM2
staining)
Anatomic Pathology Surgical Pathology ER and/or PgR,IHC staining and path Y PM2
interp on-site
Anatomic Pathology Surgical Pathology Ex-vivo use of in-vivo microscopy Y
(IVM) technology
Anatomic Pathology Surgical Pathology Gross evaluation, non-pathologist Y
Anatomic Pathology Surgical Pathology Gross evaluation, pathologist Y
Anatomic Pathology Surgical Pathology HER2, breast, IHC path interp (off-site Y HER2
staining)
Anatomic Pathology Surgical Pathology HER2, breast, IHC stain and path interp Y HER2
on-site
Anatomic Pathology Surgical Pathology HER2, gastric, IHC path interp on-site Y
Anatomic Pathology Surgical Pathology Image analysis Y
Anatomic Pathology Surgical Pathology KOH prep, Surgical Pathology Y
Anatomic Pathology Surgical Pathology Laboratory developed test(LDT), Y
Surgical Pathology
Anatomic Pathology Surgical Pathology Microscopic evaluation, Surgical Y
Pathology
Anatomic Pathology Surgical Pathology Oral pathology only (oral specimen Y
exam)
Anatomic Pathology Surgical Pathology Pathologist interpretation, FNA Y
Anatomic Pathology Surgical Pathology Skin scrapings for parasites, Surgical Y
Pathology
Anatomic Pathology Surgical Pathology Tzanck smears interp, Surgical Pathology Y
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 53 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Clinical Biochemical Clinical Biochemical Genetics Carbohydrate deficient transferrin
Genetics
Clinical Biochemical Clinical Biochemical Genetics Carbohydrate, urine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Carnitine palmitoyltransferase
Genetics
Clinical Biochemical Clinical Biochemical Genetics Carnitine transport, fibroblasts
Genetics
Clinical Biochemical Clinical Biochemical Genetics Carnitine, blood spot
Genetics
Clinical Biochemical Clinical Biochemical Genetics Carnitine, serum/plasma Y BGL1
Genetics
Clinical Biochemical Clinical Biochemical Genetics Ceramide accumulation (Farber disease)
Genetics
Clinical Biochemical Clinical Biochemical Genetics Ceramide trihexoside/sulfatide
Genetics accumulation, urine
Clinical Biochemical Clinical Biochemical Genetics Chitotriosidase
Genetics
Clinical Biochemical Clinical Biochemical Genetics Cholesterol esterification (Niemann Pick
Genetics Type C)
Clinical Biochemical Clinical Biochemical Genetics Coenzyme Q10
Genetics
Clinical Biochemical Clinical Biochemical Genetics Colorimetry (stand alone) Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics Coproporphyrin isomers
Genetics
Clinical Biochemical Clinical Biochemical Genetics Coproporphyrins Y N, NX
Genetics
Clinical Biochemical Clinical Biochemical Genetics Creatine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Creatine transport, fibroblasts
Genetics
Clinical Biochemical Clinical Biochemical Genetics Creatinine, serum/plasma Y AQ2, AQ4, C1, C3, C3X, C4, CZ,
Genetics CZ2X, CZX, WBCR
Clinical Biochemical Clinical Biochemical Genetics Creatinine, urine, quantitative Y BU, CD, U, UDC
Genetics
Clinical Biochemical Clinical Biochemical Genetics Cystine, urine
Genetics
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 54 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Clinical Biochemical Clinical Biochemical Genetics Dehydrocholesterol (7-DHC, 8-DHC)
Genetics
Clinical Biochemical Clinical Biochemical Genetics Delta aminolevulinic acid, quantitative
Genetics
Clinical Biochemical Clinical Biochemical Genetics Deoxypyridinoline (DPD)
Genetics
Clinical Biochemical Clinical Biochemical Genetics Dihydropterin reductase, blood spot
Genetics
Clinical Biochemical Clinical Biochemical Genetics Electrophoresis or isoelectric focusing Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics Enzymology (Biochemical Genetics) Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics Fatty acid profile
Genetics
Clinical Biochemical Clinical Biochemical Genetics Fatty acid profile, peroxisomal,
Genetics serum/plasma
Clinical Biochemical Clinical Biochemical Genetics Fatty acids, free (non-esterified)
Genetics
Clinical Biochemical Clinical Biochemical Genetics Filipin staining, cultured cells
Genetics
Clinical Biochemical Clinical Biochemical Genetics Frataxin
Genetics
Clinical Biochemical Clinical Biochemical Genetics Fructose 1,6 biphosphatase
Genetics
Clinical Biochemical Clinical Biochemical Genetics Fructose aldolase
Genetics
Clinical Biochemical Clinical Biochemical Genetics G-6-PD screen
Genetics
Clinical Biochemical Clinical Biochemical Genetics Galactitol, urine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Galactokinase, blood
Genetics
Clinical Biochemical Clinical Biochemical Genetics Galactose
Genetics
Clinical Biochemical Clinical Biochemical Genetics Galactose-1-phosphate uridyltransferase
Genetics
Clinical Biochemical Clinical Biochemical Genetics Galactose-1-phosphate, RBC
Genetics
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 55 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Clinical Biochemical Clinical Biochemical Genetics Gamma-aminobutyric acid (GABA),
Genetics free, CSF
Clinical Biochemical Clinical Biochemical Genetics Gamma-aminobutyric acid (GABA),
Genetics total, CSF
Clinical Biochemical Clinical Biochemical Genetics Gas chromatography (GC) Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics Gas chromatography/mass spectrometry Y
Genetics (GC/MS)
Clinical Biochemical Clinical Biochemical Genetics Globotriaosylceramide (GB3), urine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Globotriaosylsphingosine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Glucopsychosine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Glucose tetramer (HEX4), urine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Glucose-6-phosphatase
Genetics
Clinical Biochemical Clinical Biochemical Genetics Glutaryl CoA dehydrogenase
Genetics
Clinical Biochemical Clinical Biochemical Genetics Glutarylcarnitine, quantitative, urine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Glycogen
Genetics
Clinical Biochemical Clinical Biochemical Genetics Guanidinoacetate/creatine, quantitative
Genetics
Clinical Biochemical Clinical Biochemical Genetics High performance liquid chromatography Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics Homocysteine, blood spot
Genetics
Clinical Biochemical Clinical Biochemical Genetics Homocysteine, serum/plasma Y HMS
Genetics
Clinical Biochemical Clinical Biochemical Genetics Homocysteine, urine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Homovanillic acid (HVA), CSF
Genetics
Clinical Biochemical Clinical Biochemical Genetics Hormone analysis, newborn screening,
Genetics blood spot
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 56 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Clinical Biochemical Clinical Biochemical Genetics Hydroxyproline
Genetics
Clinical Biochemical Clinical Biochemical Genetics Hyperoxaluria panel
Genetics
Clinical Biochemical Clinical Biochemical Genetics Immunoassay Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics Immunoreactive trypsinogen, blood spot
Genetics
Clinical Biochemical Clinical Biochemical Genetics Insulin binding, fibroblasts
Genetics
Clinical Biochemical Clinical Biochemical Genetics Ion exhange chromatography Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics Keto acids
Genetics
Clinical Biochemical Clinical Biochemical Genetics Laboratory developed test (LDT), CBG Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics Lactate, CSF Y M, OLI
Genetics
Clinical Biochemical Clinical Biochemical Genetics Liquid scintillation counter Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics Lysophosphatidylcholine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Lysosomal enzymes (storage disorders)
Genetics
Clinical Biochemical Clinical Biochemical Genetics MALDI TOF mass spectrometry Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics MS ID by selected ion monitoring Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics MS ID by total current Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics Metabolic disorders, blood spot
Genetics
Clinical Biochemical Clinical Biochemical Genetics Metabolic screen, urine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Methylmalonic acid
Genetics
Clinical Biochemical Clinical Biochemical Genetics Mucopolysaccharides
Genetics (Glycosaminoglycans), bld spot
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 57 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Clinical Biochemical Clinical Biochemical Genetics Mucopolysaccharides Y BGL
Genetics (Glycosaminoglycans), urine
Clinical Biochemical Clinical Biochemical Genetics N-glycan
Genetics
Clinical Biochemical Clinical Biochemical Genetics O-glycan
Genetics
Clinical Biochemical Clinical Biochemical Genetics Oligosaccharide screen
Genetics
Clinical Biochemical Clinical Biochemical Genetics Organic acids, blood spot
Genetics
Clinical Biochemical Clinical Biochemical Genetics Organic acids, serum/plasma
Genetics
Clinical Biochemical Clinical Biochemical Genetics Orotic acid, urine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Oxysterols
Genetics
Clinical Biochemical Clinical Biochemical Genetics Palmitoyl-protein thioesterase 1 (PPT1)
Genetics
Clinical Biochemical Clinical Biochemical Genetics Peroxisomal enzymes, fibroblasts
Genetics
Clinical Biochemical Clinical Biochemical Genetics Phenylalanine (PKU)
Genetics
Clinical Biochemical Clinical Biochemical Genetics Phenylbutyrate metabolites
Genetics
Clinical Biochemical Clinical Biochemical Genetics Phosphofructokinase (PFK)
Genetics
Clinical Biochemical Clinical Biochemical Genetics Phosphomannomutase (PMM)
Genetics
Clinical Biochemical Clinical Biochemical Genetics Phosphomannose isomerase (PMI)
Genetics
Clinical Biochemical Clinical Biochemical Genetics Phosphorylase B kinase
Genetics
Clinical Biochemical Clinical Biochemical Genetics Phosphorylase enzymes
Genetics
Clinical Biochemical Clinical Biochemical Genetics Pipecolic acid
Genetics
Clinical Biochemical Clinical Biochemical Genetics Piperideine-6-carboxylic acid
Genetics
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 58 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Clinical Biochemical Clinical Biochemical Genetics Polyols, urine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Porphobilinogen
Genetics
Clinical Biochemical Clinical Biochemical Genetics Porphobilinogen deaminase
Genetics
Clinical Biochemical Clinical Biochemical Genetics Porphyrins, quantitative
Genetics
Clinical Biochemical Clinical Biochemical Genetics Psychosine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Pterins, urine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Purine/pyrimidine panel
Genetics
Clinical Biochemical Clinical Biochemical Genetics Pyridinoline (PYD)
Genetics
Clinical Biochemical Clinical Biochemical Genetics Pyruvate dehydrogenase complex,
Genetics fibroblasts
Clinical Biochemical Clinical Biochemical Genetics Pyruvate, CSF
Genetics
Clinical Biochemical Clinical Biochemical Genetics Pyruvate, serum/plasma
Genetics
Clinical Biochemical Clinical Biochemical Genetics Pyruvate, whole blood
Genetics
Clinical Biochemical Clinical Biochemical Genetics Radioimmunoassay (RIA) Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics Sialic acid, total
Genetics
Clinical Biochemical Clinical Biochemical Genetics Spectrofluorometry (stand alone) Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics Sterols, serum/plasma
Genetics
Clinical Biochemical Clinical Biochemical Genetics Succinylacetone
Genetics
Clinical Biochemical Clinical Biochemical Genetics Succinyladenosine, CSF
Genetics
Clinical Biochemical Clinical Biochemical Genetics Succinylpurine screen
Genetics
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 59 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Clinical Biochemical Clinical Biochemical Genetics Sulfatides
Genetics
Clinical Biochemical Clinical Biochemical Genetics Sulfite, urine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Sulfocysteine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Symmetric dimethylarginine (SDMA),
Genetics serum/plasma
Clinical Biochemical Clinical Biochemical Genetics Tandem mass spectrometry Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics Tartrate resistant acid phosphatase
Genetics (TRAP)
Clinical Biochemical Clinical Biochemical Genetics Tetrahydrobiopterin & neopterin profile,
Genetics CSF
Clinical Biochemical Clinical Biochemical Genetics Thin layer chromatography (TLC) Y
Genetics
Clinical Biochemical Clinical Biochemical Genetics Thiopurine methyltransferase enzyme
Genetics
Clinical Biochemical Clinical Biochemical Genetics Transthyretin
Genetics
Clinical Biochemical Clinical Biochemical Genetics Trimethylamine, urine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Tripeptidyl peptidase 1 (TPP1)
Genetics
Clinical Biochemical Clinical Biochemical Genetics UDP-galactose-4-epimerase, RBC
Genetics
Clinical Biochemical Clinical Biochemical Genetics Urinary organic acids, qualitative Y BGL
Genetics
Clinical Biochemical Clinical Biochemical Genetics Urinary organic acids, quantitative
Genetics
Clinical Biochemical Clinical Biochemical Genetics Uroporphyrin Y N, NX
Genetics
Clinical Biochemical Clinical Biochemical Genetics Uroporphyrinogen III cosynthase
Genetics
Clinical Biochemical Clinical Biochemical Genetics Uroporphyrinogen decarboxylase
Genetics
Clinical Biochemical Clinical Biochemical Genetics Very long chain acyl-CoA dehydrogenase
Genetics (VLCAD)
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 60 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Clinical Biochemical Clinical Biochemical Genetics Very long chain lysophosphatidylcholine
Genetics
Clinical Biochemical Clinical Biochemical Genetics Vitamin B6
Genetics
Clinical Biochemical Clinical Biochemical Genetics Zinc protoporphyrins
Genetics
Clinical Biochemical Newborn Screening Newborn screening, blood spot Y
Genetics
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 62 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Cytogenetics In Situ Hybridization Urothelial CA hybrid only (off-site
interp), FISH
Cytogenetics In Situ Hybridization Urothelial CA interp only (off-site
hybrid), FISH
Cytogenetics In Situ Hybridization Urothelial carcinoma hybrid & interp on- Y CYI
site, FISH
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 72 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Hematology Hematology Parasite screening/identification, blood Y BP, P, P3, P4, P5
Hematology Hematology Plasmodium antigens (rapid malaria)
Hematology Hematology Platelet count, automated Y FH1, FH10, FH10P, FH13, FH13P,
FH14, FH14P, FH15, FH1P, FH2,
FH2P, FH3, FH3P, FH4, FH4P, FH6,
FH6P, FH9, FH9P, HE, HEP
Hematology Hematology Platelet count, manual Y FH1, FH10, FH10P, FH13, FH13P,
FH14, FH14P, FH15, FH1P, FH2,
FH2P, FH3, FH3P, FH4, FH4P, FH6,
FH6P, FH9, FH9P, HE, HEP
Hematology Hematology Platelet count, platelet-rich plasma Y TRC
Hematology Hematology RBC count Y FH1, FH10, FH10P, FH13, FH13P,
FH14, FH14P, FH1P, FH2, FH2P,
FH3, FH3P, FH4, FH4P, FH6, FH6P,
FH9, FH9P, HE, HEP
Hematology Hematology RBC indices (e.g. MCV, RDW)
Hematology Hematology Reticulocyte count, automated Y FH14, FH14P, RT, RT2, RT3, RT4
Hematology Hematology Reticulocyte count, manual Y FH14, FH14P, RT, RT2, RT3, RT4
Hematology Hematology Reticulocyte hemoglobin content
Hematology Hematology Sickling test, hemoglobin solubility Y HG, SCS
Hematology Hematology Special stains, Hematology Y
Hematology Hematology Sugar water test
Hematology Hematology Viscosity, serum/plasma
Hematology Hematology Viscosity, whole blood
Hematology Hematology WBC count, automated Y FH1, FH10, FH10P, FH13, FH13P,
FH14, FH14P, FH15, FH1P, FH2,
FH2P, FH3, FH3P, FH4, FH4P, FH6,
FH6P, FH9, FH9P, HE, HEP, RWBC
Hematology Hematology WBC count, manual Y FH1, FH10, FH10P, FH13, FH13P,
FH14, FH14P, FH15, FH1P, FH2,
FH2P, FH3, FH3P, FH4, FH4P, FH6,
FH6P, FH9, FH9P, HE, HEP, RWBC
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 104 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Microbiology Molecular Microbiology CMV, qualitative, amplification (not
FDA-approved)
Microbiology Molecular Microbiology CMV, quantitative, amplification (FDA-
approved)
Microbiology Molecular Microbiology CMV,quantitative, amplification (not
FDA-approved)
Microbiology Molecular Microbiology Candida spp., DNA probe (FDA- Y CRYP, F, F1, F3, VS
approved)
Microbiology Molecular Microbiology Candida spp., DNA probe (not FDA- Y CRYP, F, F1, F3, VS
approved)
Microbiology Molecular Microbiology Candida spp., nucleic acid amplif. (FDA-
approved)
Microbiology Molecular Microbiology Candida spp., nucleic acid amplif. (not
FDA-app)
Microbiology Molecular Microbiology Chikungunya virus, amplif.(EUA/not
FDA-approved)
Microbiology Molecular Microbiology Chlamydia trachomatis, DNA probe Y BDP5, BDPV5, D, D1, D2, D3, D4,
(FDA-approved) D7, D8, GIP5, HC6, HC6X, HC7,
IDR, MC1, MC2, MC4, MC5,
MRS5, MRS5M
Microbiology Molecular Microbiology Chlamydia trachomatis, DNA probe (not Y BDP5, BDPV5, D, D1, D2, D3, D4,
FDA-app) D7, D8, GIP5, HC6, HC6X, HC7,
IDR, MC1, MC2, MC4, MC5,
MRS5, MRS5M
Microbiology Molecular Microbiology Chlamydia trachomatis, NAA (FDA- Y BDP5, BDPV5, D, D1, D2, D3, D4,
approved) D7, D8, GIP5, HC6, HC6X, HC7,
IDR, MC1, MC2, MC4, MC5,
MRS5, MRS5M
Microbiology Molecular Microbiology Chlamydia trachomatis, NAA (not FDA- Y BDP5, BDPV5, D, D1, D2, D3, D4,
approved) D7, D8, GIP5, HC6, HC6X, HC7,
IDR, MC1, MC2, MC4, MC5,
MRS5, MRS5M
Microbiology Molecular Microbiology Chlamydia trachomatis, signal amp (FDA Y BDP5, BDPV5, D, D1, D2, D3, D4,
approved) D7, D8, GIP5, HC6, HC6X, HC7,
IDR, MC1, MC2, MC4, MC5,
MRS5, MRS5M
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 107 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Microbiology Molecular Microbiology HCV, NAT, blood/tissue donors (not Y NAT
FDA-approved)
Microbiology Molecular Microbiology HCV, quantitative, amplification (FDA- Y HCV2
approved)
Microbiology Molecular Microbiology HCV, quantitative, amplification (not Y HCV2
FDA-app)
Microbiology Molecular Microbiology HIV genotyping (FDA-approved)
Microbiology Molecular Microbiology HIV genotyping (not FDA-approved)
Microbiology Molecular Microbiology HIV phenotyping (not FDA-approved)
Microbiology Molecular Microbiology HIV qualitative, amplification (FDA-
approved)
Microbiology Molecular Microbiology HIV qualitative, amplification (not FDA-
approved)
Microbiology Molecular Microbiology HIV, NAT, blood/tissue donors (FDA- Y NAT
approved)
Microbiology Molecular Microbiology HIV, NAT, blood/tissue donors (not FDA- Y NAT
approved)
Microbiology Molecular Microbiology HIV-RNA, quant, amplification (FDA- Y HV2
approved)
Microbiology Molecular Microbiology HIV-RNA, quantitative, amplification Y HV2
(not FDA-app)
Microbiology Molecular Microbiology HPV genotyping (FDA-approved)
Microbiology Molecular Microbiology HPV genotyping (not FDA-approved)
Microbiology Molecular Microbiology HPV, formalin paraffin embedded, NAA
(not FDA-app)
Microbiology Molecular Microbiology HPV, nucleic acid amplification (FDA- Y CHPVD, CHPVJ, CHPVK, CHPVM,
approved) GIP5, HC4, HPV, ID3, IDR, VR1
Microbiology Molecular Microbiology HPV, nucleic acid amplification (not Y CHPVD, CHPVJ, CHPVK, CHPVM,
FDA-approved) GIP5, HC4, HPV, ID3, IDR, VR1
Microbiology Molecular Microbiology HPV, signal amplification (FDA- Y CHPVD, CHPVJ, CHPVK, CHPVM,
approved) GIP5, HC4, HPV, ID3, IDR, VR1
Microbiology Molecular Microbiology HPV, signal amplification (not FDA- Y CHPVD, CHPVJ, CHPVK, CHPVM,
approved) GIP5, HC4, HPV, ID3, IDR, VR1
Microbiology Molecular Microbiology HSV, qualitative, amplification (FDA- Y CHPVD, CHPVJ, CHPVK, CHPVM,
approved) GIP5, HC2, HC4, ID3, IDR, VR1,
VR2, VR4
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 109 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Microbiology Molecular Microbiology KPC, nucleic acid amplif. (not FDA-
approved)
Microbiology Molecular Microbiology Laboratory developed test (LDT), Y
Molecular Micro
Microbiology Molecular Microbiology Legionella spp., nucleic acid amplif.
(FDA-app)
Microbiology Molecular Microbiology Legionella spp., nucleic acid amplif.(not
FDA-app)
Microbiology Molecular Microbiology MERS-CoV, amplification (EUA/not
FDA-approved)
Microbiology Molecular Microbiology MRSA/SA, nucleic acid amplif. (FDA- Y BDP5, BDPV5, D, D1, D2, D3, D4,
approved) D7, D8, GIP5, HC6, HC6X, HC7,
IDR, MC1, MC2, MC4, MC5, MRS,
MRS2M, MRS5, MRS5M
Microbiology Molecular Microbiology MRSA/SA, nucleic acid amplif. (not Y BDP5, BDPV5, D, D1, D2, D3, D4,
FDA-app) D7, D8, GIP5, HC6, HC6X, HC7,
IDR, MC1, MC2, MC4, MC5, MRS,
MRS2M, MRS5, MRS5M
Microbiology Molecular Microbiology Microbiome ratio, quantitation, PCR (not
FDA-app)
Microbiology Molecular Microbiology Molecular infectious disease testing Y
Microbiology Molecular Microbiology Multiplex panels, PCR Y
Microbiology Molecular Microbiology Mycobacteria ID other, NAA (not FDA-
approved)
Microbiology Molecular Microbiology Mycobacterium tb/complex, amplif.
(FDA-app)
Microbiology Molecular Microbiology Mycobacterium tb/complex, amplif. (not
FDA-app)
Microbiology Molecular Microbiology Mycobacterium tuberculosis, NAA (not
FDA-app)
Microbiology Molecular Microbiology Mycoplasma pneumoniae, NAA (FDA-
approved)
Microbiology Molecular Microbiology Mycoplasma pneumoniae, NAA (not
FDA-approved)
Microbiology Molecular Microbiology N. gonorrhoeae, DNA probe (FDA- Y BDP5, BDPV5, D, D1, D2, D3, D4,
approved) D7, D8, GIP5, HC6, HC6X, HC7,
IDR, MC1, MC2, MC4, MC5,
MRS5, MRS5M
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 110 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Microbiology Molecular Microbiology N. gonorrhoeae, DNA probe (not FDA- Y BDP5, BDPV5, D, D1, D2, D3, D4,
approved) D7, D8, GIP5, HC6, HC6X, HC7,
IDR, MC1, MC2, MC4, MC5,
MRS5, MRS5M
Microbiology Molecular Microbiology N. gonorrhoeae, nucleic acid amp (FDA- Y BDP5, BDPV5, D, D1, D2, D3, D4,
approved) D7, D8, GIP5, HC6, HC6X, HC7,
IDR, MC1, MC2, MC4, MC5,
MRS5, MRS5M
Microbiology Molecular Microbiology N. gonorrhoeae, nucleic acid amplif. (not Y BDP5, BDPV5, D, D1, D2, D3, D4,
FDA-app) D7, D8, GIP5, HC6, HC6X, HC7,
IDR, MC1, MC2, MC4, MC5,
MRS5, MRS5M
Microbiology Molecular Microbiology N. gonorrhoeae, signal amp (FDA- Y BDP5, BDPV5, D, D1, D2, D3, D4,
approved) D7, D8, GIP5, HC6, HC6X, HC7,
IDR, MC1, MC2, MC4, MC5,
MRS5, MRS5M
Microbiology Molecular Microbiology N. gonorrhoeae, signal amplification (not Y BDP5, BDPV5, D, D1, D2, D3, D4,
FDA-app) D7, D8, GIP5, HC6, HC6X, HC7,
IDR, MC1, MC2, MC4, MC5,
MRS5, MRS5M
Microbiology Molecular Microbiology Norovirus, nucleic acid amplif. (FDA-
approved)
Microbiology Molecular Microbiology Norovirus, nucleic acid amplif. (not
FDA-approved)
Microbiology Molecular Microbiology Nucleic acid amplification Y
Microbiology Molecular Microbiology Nucleic acid extraction Y
Microbiology Molecular Microbiology Parainfluenza, nucleic acid amplif. (not
FDA-app)
Microbiology Molecular Microbiology Parainfluenza, nucleic acid
amplification(FDA-app)
Microbiology Molecular Microbiology Parasite ID, gastrointestinal panel (FDA-
app)
Microbiology Molecular Microbiology Parasite ID, gastrointestinal panel (not
FDA-app)
Microbiology Molecular Microbiology Parasite ID, meningitis panel (not FDA-
approved)
Microbiology Molecular Microbiology Parasite ID, nucleic acid amplif. (FDA-
approved)
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 123 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Molecular Pathology Molecular Pathology Myotonic dystrophy, molec. methods Y MGL2
Molecular Pathology Molecular Pathology NRAS, molecular methods
Molecular Pathology Molecular Pathology Neoplastic disorders, non-paraffin
embedded, ISH
Molecular Pathology Molecular Pathology Neoplastic disorders, paraffin embedded,
ISH
Molecular Pathology Molecular Pathology Neuroblastoma, molecular methods
Molecular Pathology Molecular Pathology Neurofibromatosis, molecular methods
Molecular Pathology Molecular Pathology Niemann-Pick disease, molecular Y MGL4
methods
Molecular Pathology Molecular Pathology Non-invasive prenatal testing (NIPT),
molecular
Molecular Pathology Molecular Pathology Noonan syndrome, molecular methods
Molecular Pathology Molecular Pathology Nucleic acid amplification Y
Molecular Pathology Molecular Pathology Nucleic acid extraction Y
Molecular Pathology Molecular Pathology Opitz G/BBB syndrome, molecular meth
Molecular Pathology Molecular Pathology PML/RARA, qualitative, molecular
Molecular Pathology Molecular Pathology PML/RARA, quantitative, molecular
Molecular Pathology Molecular Pathology Parkinson disease, molecular methods
Molecular Pathology Molecular Pathology Pfeiffer syndrome, molecular methods
Molecular Pathology Molecular Pathology Pharmacogenetic assays (e.g. UGT1A1,
VKORC1)
Molecular Pathology Molecular Pathology Phenylketonuria (PKU), molecular
methods
Molecular Pathology Molecular Pathology Plasminogen activator inhibitor (PAI-1),
molecular
Molecular Pathology Molecular Pathology Polycystic kidney disease, molecular
methods
Molecular Pathology Molecular Pathology Prader-Willi/Angelman syndrome, molec. Y MGL1
methods
Molecular Pathology Molecular Pathology Preimplantation genetic diagnosis (PGD),
FISH
Molecular Pathology Molecular Pathology Preimplantation genetic diagnosis (PGD),
PCR
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 129 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Point-of-Care Testing Point of Care Testing - Non-Waived HDL cholesterol, whole blood, non- Y C1, C3, C3X, C4, CZ, CZ2X, CZX
waived, POCT
Point-of-Care Testing Point of Care Testing - Non-Waived HIV-1/2 antibody/p24 antigen,rapid,non- Y AHIV, VM1, VM6, VM6X
waived,POCT
Point-of-Care Testing Point of Care Testing - Non-Waived Hematocrit (direct measure/calc), non- Y AQ, AQ2, AQ3, AQ4, FH1, FH10,
waived, POCT FH10P, FH13, FH13P, FH14, FH14P,
FH15, FH1P, FH2, FH2P, FH3,
FH3P, FH4, FH4P, FH6, FH6P, FH9,
FH9P, HE, HEP, SO
Point-of-Care Testing Point of Care Testing - Non-Waived Hemoglobin A1C, non-waived, POCT Y GH5, GH5I
Point-of-Care Testing Point of Care Testing - Non-Waived Hemoglobin, estimated, POCT Y AQ, AQ2, AQ3, AQ4, FH1, FH10,
FH10P, FH13, FH13P, FH14, FH14P,
FH15, FH1P, FH2, FH2P, FH3,
FH3P, FH4, FH4P, FH6, FH6P, FH9,
FH9P, HE, HEP, SO
Point-of-Care Testing Point of Care Testing - Non-Waived Hemoglobin, plasma, POCT
Point-of-Care Testing Point of Care Testing - Non-Waived Hemoglobin, total, non-waived, POCT Y AQ, AQ2, AQ3, AQ4, FH1, FH10,
FH10P, FH13, FH13P, FH14, FH14P,
FH15, FH1P, FH2, FH2P, FH3,
FH3P, FH4, FH4P, FH6, FH6P, FH9,
FH9P, HE, HEP, SO
Point-of-Care Testing Point of Care Testing - Non-Waived Heparin assay (heparin/protamine
titration), POCT
Point-of-Care Testing Point of Care Testing - Non-Waived Heparin dose response, POCT
Point-of-Care Testing Point of Care Testing - Non-Waived IGFBP-1, rapid, amniotic fluid, POCT
Point-of-Care Testing Point of Care Testing - Non-Waived INR, whole blood, non-waived, POCT Y CGB, CGL, WP3, WP4, WP6, WP9
Point-of-Care Testing Point of Care Testing - Non-Waived Infectious mononucleosis, non-waived, Y IL, IM
POCT
Point-of-Care Testing Point of Care Testing - Non-Waived Influenza antigen, non-waived, POCT Y HC2, VR2, VR4
Point-of-Care Testing Point of Care Testing - Non-Waived Influenza, rapid NAA, non-waived, Y CHPVD, CHPVJ, CHPVK, CHPVM,
POCT GIP5, HC2, HC4, ID3, IDR, VR1,
VR2, VR4
Point-of-Care Testing Point of Care Testing - Non-Waived KOH prep, POCT Y CMMP, FSM
Point-of-Care Testing Point of Care Testing - Non-Waived Ketone, whole blood, non-waived, POCT
Point-of-Care Testing Point of Care Testing - Non-Waived LDL cholesterol, whole blood, non-
waived, POCT
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 132 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Point-of-Care Testing Point of Care Testing - Non-Waived Urea, whole blood, non-waived, POCT Y AQ2, AQ4, C1, C3, C3X, C4, CZ,
CZ2X, CZX
Point-of-Care Testing Point of Care Testing - Non-Waived Urinalysis dipstick, automated, non- Y CMP, CMP1, HCC2
waived, POCT
Point-of-Care Testing Point of Care Testing - Non-Waived Urine drug screen, single use kit, non- Y DMPM, T, UDS, UDS6, UT
waived, POC
Point-of-Care Testing Point of Care Testing - Non-Waived Urine sediment, microscopic, POCT Y CMMP, CMP, CMP1
Point-of-Care Testing Point of Care Testing - Non-Waived Vaginal wet mount, POCT Y CMMP
Point-of-Care Testing Point of Care Testing - Non-Waived WBC count, microcuvette, POCT Y FH1, FH10, FH10P, FH13, FH13P,
FH14, FH14P, FH15, FH1P, FH2,
FH2P, FH3, FH3P, FH4, FH4P, FH6,
FH6P, FH9, FH9P, HE, HEP, RWBC
Point-of-Care Testing Point of Care Testing - Non-Waived hCG, qualitative, serum, POCT Y C1, C3, C3X, C4, CZ, CZ2X, CZX,
FP, FP1T, FPX, HCG, IL, K, KK
Point-of-Care Testing Point of Care Testing - Non-Waived hCG, qualitative, whole blood, POCT Y C1, C3, C3X, C4, CZ, CZ2X, CZX,
FP, FP1T, FPX, HCG, IL, K, KK
Point-of-Care Testing Point of Care Testing - Non-Waived hCG, quantitative, whole blood, POCT Y C1, C3, C3X, C4, CZ, CZ2X, CZX,
FP, FP1T, FPX, HCG, IL, K, KK
Point-of-Care Testing Point of Care Testing - Non-Waived hCG, urine, non-waived, POCT Y CMP, CMP1, HCC2, UHCG
Point-of-Care Testing Point of Care Testing - Non-Waived pH, gastric, non-waived, POCT
Point-of-Care Testing Point of Care Testing - Non-Waived pH, other, non-waived, POCT
Point-of-Care Testing Point of Care Testing - Non-Waived pH, scalp, POCT
Point-of-Care Testing Point of Care Testing - Non-Waived pH, vaginal/amniotic fluid, non-waived,
POCT
Point-of-Care Testing Point of Care Testing - Non-Waived pH, whole blood, POCT Y AQ, AQ2, AQ3, AQ4
Point-of-Care Testing Point of Care Testing - Provider Direct wet mount, provider performed
Performed
Point-of-Care Testing Point of Care Testing - Provider Eosinophils, nasal smear, provider
Performed performed
Point-of-Care Testing Point of Care Testing - Provider Fecal leukocytes, provider performed
Performed
Point-of-Care Testing Point of Care Testing - Provider Fern test, provider performed
Performed
Point-of-Care Testing Point of Care Testing - Provider H. pylori detection, urease, waived,
Performed provider perf
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 136 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Point-of-Care Testing Point of Care Testing - Waived Nicotine/Cotinine rapid test, waived,
POCT
Point-of-Care Testing Point of Care Testing - Waived Occult blood, fecal, waived, POCT
Point-of-Care Testing Point of Care Testing - Waived Occult blood, gastric, waived, POCT
Point-of-Care Testing Point of Care Testing - Waived Osmolarity, tears, waived, POCT
Point-of-Care Testing Point of Care Testing - Waived Ovulation test (LH), waived, POCT
Point-of-Care Testing Point of Care Testing - Waived PT, whole blood, waived, POCT
Point-of-Care Testing Point of Care Testing - Waived Phosphorus, whole blood, waived, POCT Y C1, C3, C3X, CZ, CZ2X, CZX
Point-of-Care Testing Point of Care Testing - Waived Platelet function, rapid, aspirin, waived,
POCT
Point-of-Care Testing Point of Care Testing - Waived Potassium, whole blood, waived, POCT Y AQ, AQ2, AQ3, AQ4, C1, C3, C3X,
C4, CZ, CZ2X, CZX
Point-of-Care Testing Point of Care Testing - Waived Protein, total, whole blood, waived, Y C1, C3, C3X, CZ, CZ2X, CZX
POCT
Point-of-Care Testing Point of Care Testing - Waived RSV antigen, non-DFA method, waived, Y HC2, VR2, VR4
POCT
Point-of-Care Testing Point of Care Testing - Waived RSV, rapid NAA, waived, POCT Y CHPVD, CHPVJ, CHPVK, CHPVM,
GIP5, HC2, HC4, ID3, IDR, VR1,
VR2, VR4
Point-of-Care Testing Point of Care Testing - Waived Reducing substances, urine, POCT Y CMP, CMP1, HCC2
Point-of-Care Testing Point of Care Testing - Waived Sodium, whole blood, waived, POCT Y AQ, AQ2, AQ3, AQ4, C1, C3, C3X,
C4, CZ, CZ2X, CZX
Point-of-Care Testing Point of Care Testing - Waived Specific gravity, waived, POCT Y CMP, CMP1, HCC2
Point-of-Care Testing Point of Care Testing - Waived Specimen integrity testing, urine, waived,
POCT
Point-of-Care Testing Point of Care Testing - Waived Sperm count screen, rapid test, waived,
POCT
Point-of-Care Testing Point of Care Testing - Waived Strep A rapid antigen, waived, POCT Y CDF5, D, D4, D6, D9, HC1, HC3,
HPS, LBAS, MC1, MC2, MC4,
MC5, SBAS, VS
Point-of-Care Testing Point of Care Testing - Waived Strep A, rapid NAA, waived, POCT Y BDP5, BDPV5, D, D1, D2, D3, D4,
D7, D8, GIP5, HC6, HC6X, HC7,
IDR, MC1, MC2, MC4, MC5,
MRS5, MRS5M
Point-of-Care Testing Point of Care Testing - Waived Syphilis antibodies, rapid test, waived, Y G
POCT
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 137 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Point-of-Care Testing Point of Care Testing - Waived TSH rapid screen, whole blood, waived, Y C1, C3, C3X, CZ, CZ2X, CZX, K,
POCT KK
Point-of-Care Testing Point of Care Testing - Waived Trichomonas antigen, waived, POCT Y VS, VS1
Point-of-Care Testing Point of Care Testing - Waived Triglycerides, whole blood, waived, Y C1, C3, C3X, C4, CZ, CZ2X, CZX,
POCT LCW
Point-of-Care Testing Point of Care Testing - Waived Urea, whole blood, waived, POCT Y AQ2, AQ4, C1, C3, C3X, C4, CZ,
CZ2X, CZX
Point-of-Care Testing Point of Care Testing - Waived Uric acid, whole blood, waived, POCT Y C1, C3, C3X, C4, CZ, CZ2X, CZX
Point-of-Care Testing Point of Care Testing - Waived Urinalysis dipstick, automated, waived, Y CMP, CMP1, HCC2
POCT
Point-of-Care Testing Point of Care Testing - Waived Urinalysis dipstick, manual, waived, Y CMP, CMP1, HCC2
POCT
Point-of-Care Testing Point of Care Testing - Waived Urine drug screen, single use kit, waived, Y DMPM, T, UDS, UDS6, UT
POCT
Point-of-Care Testing Point of Care Testing - Waived hCG, urine, waived, POCT Y CMP, CMP1, HCC2, UHCG
Point-of-Care Testing Point of Care Testing - Waived pH, gastric, waived, POCT
Point-of-Care Testing Point of Care Testing - Waived pH, other, waived, POCT
Point-of-Care Testing Point of Care Testing - Waived pH, vaginal/amniotic fluid, waived,
POCT
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
College of American Pathologists MALP_MALS
Master Activity Menu
Page 140 of 144
With Proficiency Testing Options 05/01/2019 08:01 AM
Program: LAP As of: 05/01/2019
CAP Scope of Surveys CAP PT Options
Discipline Subdiscipline Test/Activity Accepted PT Service/Analytic
Required ** Method
Transfusion Medicine/Blood Immunohematology Direct antiglobulin test (DAT), non- Y DAT
Bank automated
Transfusion Medicine/Blood Immunohematology Donath Landsteiner
Bank
Transfusion Medicine/Blood Immunohematology Donor unit retyping Y
Bank
Transfusion Medicine/Blood Immunohematology Fetal-maternal bleed screen (rosette) Y HBF
Bank
Transfusion Medicine/Blood Immunohematology Gel techniques Y
Bank
Transfusion Medicine/Blood Immunohematology Kleihauer-Betke stain (fetal cell Y HBF
Bank quantitation)
Transfusion Medicine/Blood Immunohematology Laboratory developed test (LDT), Y
Bank Immunoheme
Transfusion Medicine/Blood Immunohematology Perinatal testing Y
Bank
Transfusion Medicine/Blood Immunohematology Platelet antibodies for crossmatching Y PS
Bank
Transfusion Medicine/Blood Immunohematology Platelet crossmatch
Bank
Transfusion Medicine/Blood Immunohematology RBC antigen typing
Bank
Transfusion Medicine/Blood Immunohematology RBC antigen typing for parentage testing
Bank only
Transfusion Medicine/Blood Immunohematology Rh type (includes weak D) Y J, J1, JAT
Bank
Transfusion Medicine/Blood Immunohematology RhIG Candidate Assessment Y
Bank
Transfusion Medicine/Blood Immunohematology Sickle cell screening on donor units
Bank
Transfusion Medicine/Blood Immunohematology Solid phase techniques Y
Bank
Transfusion Medicine/Blood Tissue Storage and Issue Storage of organ donor blood vessels Y
Bank
Transfusion Medicine/Blood Tissue Storage and Issue Tissue storage and issue Y
Bank
** CAP Accepted PT Required. For activities requiring alternative assessment, laboratories can use PT products supplied by the CAP or other providers. Laboratories should review the
Surveys catalog to determine which PT products are compatible with their specific methodologies.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.
NOTE: Activities noted as Scope of Service / Analytical Method do not require PT or alternative assessment.